Vasopressin antagonists

T Berl - New England Journal of Medicine, 2015 - Mass Medical Soc
Vasopressin Antagonists | New England Journal of Medicine Skip to main content The New
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …

Vasopressin-receptor antagonists

EJ Hoorn, R Zietse - Future Cardiology, 2010 - Taylor & Francis
Despite a crucial role in body fluid homeostasis, elevated vasopressin levels can also be
pathological in conditions such as congestive heart failure, liver cirrhosis and the syndrome …

Vasopressin: a review of therapeutic applications

NF Holt, KL Haspel - Journal of cardiothoracic and vascular …, 2010 - jcvaonline.com
VASOPRESSIN (VP) WAS DISCOVERED in 1895 from the extract of the posterior pituitary
and named for the early observation of its vasoconstrictive properties. 1 The peptide is …

The basic and clinical pharmacology of nonpeptide vasopressin receptor antagonists

M Thibonnier, P Coles, A Thibonnier… - Annual review of …, 2001 - annualreviews.org
The neurohypophysial hormone arginine vasopressin (AVP) is a cyclic nonpeptide whose
actions are mediated by the stimulation of specific G protein–coupled membrane receptors …

[引用][C] Pharmacology and clinical perspectives of vasopressin antagonists.

FA Laszlo, F Laszlo, D De Wied - Pharmacological reviews, 1991 - ASPET
2. Prevention of hyponatriaemia and cerebral oedema by V2 antagonists C. Role of
vasopressin antagonists in the release of adrenocorticotrophic hormone D. Characterization …

Physiology and pathophysiology of the vasopressinergic system

JL Vincent, F Su - Best practice & research Clinical anaesthesiology, 2008 - Elsevier
Arginine vasopressin, a hypothalamic peptide hormone, has multiple physiological
functions, including body water regulation, control of blood pressure and effects on body …

Vasopressin receptor modulators: from non-peptide antagonists to agonists

EJ Trybulski - 2001 - Elsevier
Publisher Summary This chapter elaborates the various aspects of vasopressin receptor
modulators. The cyclic peptide hormone arginine vasopressin (AVP) or antidiuretic hormone …

Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists

SB Paranjape, M Thibonnier - Expert opinion on investigational …, 2001 - Taylor & Francis
Vasopressin (AVP) is a cyclic nonapeptide hormone that exhibits many physiological effects
including free water reabsorption, vasoconstriction, cellular proliferation and …

Nonpeptide vasopressin antagonists: a new group of hormone blockers entering the scene

B Mayinger, J Hensen - Experimental and clinical …, 1999 - thieme-connect.com
After the story of success of hormone blockers for cate-cholamines, aldosterone and
angiotensin 11 and their successful implementation into clinical practice another endocrine …

Science review: vasopressin and the cardiovascular system part 1–receptor physiology

CL Holmes, DW Landry, JT Granton - Critical care, 2003 - Springer
Vasopressin is emerging as a rational therapy for vasodilatory shock states. Unlike other
vasoconstrictor agents, vasopressin also has vasodilatory properties. The goal of the …